Skip to main content

Table 9 Ehrlichia canis protection efficacy

From: Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix®) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs

Number infected (proportion)

Efficacy (%)

Control

Advantix®

NexGard™

Bravecto™

Control versus Advantix®

Control versus NexGard™

Control versus Bravecto™

6/29 (0.2068966)

0/32 (0)

4/32 (0.125)

2/32 (0.0625)

100.0

39.6

69.8